2型糖尿病治疗的新药物----Dapagliflozin

July 6, 2010 ? Dapagliflozin, a new type of drug for the treatment of type 2 diabetes, improves glycemic control independent of insulin 独立于胰岛素以外by reducing renal glucose reabsorption减少肾脏糖份的重吸收, according to a new phase 3 study presented here at the American Diabetes Association 70th Scientific Sessions and published concurrently in the June 26 issue of The Lancet.台州市中心医院中西医结合科张茂华

       Dapagliflozin, which is a selective sodium-glucose cotransporter-2 inhibitor       选择性葡萄糖-钠转运蛋白2(SGLT-2)抑制剂, works by preventing 阻止reabsorption of glucose in the kidneys and promotes the excretion of glucose in the urine促进糖份在尿液中的排泄. It thereby reduces high levels of blood glucose without affecting insulin-dependent systems.